Before innovative therapies can start helping patients, successful matches between investors and entrepreneurs seeking to develop new medicines must occur. Without access to capital, potentially lifesaving drugs will exist only as ideas. Every fall investors looking for good prospects in the biotech sector gather at the BIO Investor Forum in San Francisco—the birthplace of biotechnology and home to over 1,600 life sciences companies. Many of these companies and others from around the country come to Read More